(Q70823768)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8536519%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

title

Chronic active hepatitis and liver cirrhosis in association with combined tamoxifen/tegafur adjuvant therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8536519%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

1 reference

1 reference

S Maruyama

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8536519%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

C Hirayama

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8536519%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

J Abe

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8536519%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

J Tanaka

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8536519%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

K Matsui

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8536519%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

publication date

1 December 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8536519%20AND%20SRC:MED&resulttype=core&format=json

Digestive Diseases and Sciences

14 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8536519%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

volume

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8536519%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8536519%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

page(s)

2602-2607

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8536519%20AND%20SRC:MED&resulttype=core&format=json

Tamoxifen: disease prevention or disease substitution?

14 October 2019

cites work

1 reference

12 December 2020

Relation of estrogen and its receptor to rat liver growth and regeneration

1 reference

12 December 2020

Fatal hyperlipaemia in a case of metastatic breast cancer treated by tamoxifen

1 reference

12 December 2020

[Toxic effects of prolonged oral administration of tegafur (FT-207)]

1 reference

12 December 2020

Potential role of tamoxifen in prevention of breast cancer

1 reference

12 December 2020

Tamoxifen and liver damage

1 reference

12 December 2020

Effect of tamoxifen on hepatic regeneration in male rats

1 reference

12 December 2020

Hepatic impairment during simultaneous administration of medroxyprogesterone acetate and tamoxifen in the treatment of endometrial and ovarian carcinoma

1 reference

12 December 2020

Oral tegafur in the treatment of gastrointestinal tract cancers: a phase II study

1 reference

12 December 2020

A case of allergic liver injury induced by tegafur

1 reference

12 December 2020

A case of peliosis hepatis in association with tamoxifen therapy

1 reference

12 December 2020

Anti-oestrogen Therapy for Breast Cancer: A Trial of Tamoxifen at Two Dose Levels

1 reference

12 December 2020

Activation of Ftorafue [R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil] to 5-fluorouracil and gamma-butyrolactone

1 reference

12 December 2020

1 reference

12 December 2020

Drug-Induced Chronic Hepatic Disease

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02220448

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8536519%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

1 reference